Dhampur Bio Organics Ltd
Incorporated in 2022, Dhampur Bio Organics Ltd manufactures sugar, chemicals, ethanol,
co-generation of power and other allied products[1]
- Market Cap ₹ 687 Cr.
- Current Price ₹ 103
- High / Low ₹ 115 / 57.3
- Stock P/E 29.0
- Book Value ₹ 145
- Dividend Yield 1.21 %
- ROCE 3.97 %
- ROE 1.56 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.71 times its book value
- Company has been maintaining a healthy dividend payout of 37.7%
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 5.55% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| 0 | 1,564 | 2,408 | 1,864 | 1,862 | 2,034 | |
| 0 | 1,381 | 2,203 | 1,724 | 1,727 | 1,902 | |
| Operating Profit | -0 | 183 | 205 | 140 | 135 | 132 |
| OPM % | 12% | 8% | 8% | 7% | 6% | |
| 0 | 8 | 11 | 20 | 2 | 25 | |
| Interest | 0 | 30 | 41 | 45 | 67 | 67 |
| Depreciation | 0 | 31 | 41 | 49 | 54 | 60 |
| Profit before tax | -0 | 129 | 135 | 65 | 16 | 30 |
| Tax % | 0% | 21% | 18% | 29% | 6% | |
| -0 | 102 | 111 | 46 | 15 | 24 | |
| EPS in Rs | 16.74 | 7.00 | 2.21 | 3.58 | ||
| Dividend Payout % | 0% | 0% | 21% | 36% | 56% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -46% |
| TTM: | 114% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -13% |
| 1 Year: | 11% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 6% |
| Last Year: | 2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 66 | 66 | 66 | 66 | 66 | 66 |
| Reserves | 709 | 812 | 922 | 945 | 945 | 895 |
| 403 | 835 | 810 | 1,057 | 1,162 | 562 | |
| 373 | 287 | 278 | 244 | 223 | 121 | |
| Total Liabilities | 1,551 | 2,000 | 2,077 | 2,313 | 2,398 | 1,645 |
| 631 | 690 | 909 | 1,036 | 1,076 | 1,136 | |
| CWIP | 7 | 78 | 36 | 13 | 79 | 8 |
| Investments | 0 | 0 | 0 | 0 | 0 | 2 |
| 913 | 1,232 | 1,132 | 1,263 | 1,242 | 498 | |
| Total Assets | 1,551 | 2,000 | 2,077 | 2,313 | 2,398 | 1,645 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -0 | -246 | 368 | -101 | 130 | |
| 0 | -124 | -209 | -166 | -145 | |
| 0 | 393 | -78 | 170 | 19 | |
| Net Cash Flow | 0 | 23 | 81 | -98 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 25 | 23 | 17 | 11 | |
| Inventory Days | 341 | 163 | 288 | 288 | |
| Days Payable | 54 | 33 | 37 | 29 | |
| Cash Conversion Cycle | 312 | 154 | 269 | 270 | |
| Working Capital Days | 56 | 24 | 33 | 21 | |
| ROCE % | 11% | 10% | 5% | 4% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
23 Jan - Copies of business standard wherein the unaudited financial results of the Company for the quarter and nine month ended December 31, 2025 have been published.
-
Intimation Regarding The Complete Resumption Of Operations At Unit Mansurpur.
23 Jan - Unit Mansurpur manufacturing fully resumed from January 23, 2026; no injuries reported; assets insured; earlier notices Nov 13-14, 2025.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
22 Jan - Investor Presentation on the performance of the Company for the quarter and nine month ended December 31, 2025
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, January 21, 2026
21 Jan - Approved unaudited Q3/9M results to Dec 31, 2025; noted non-binding Planetary SA mycoprotein term sheet.
- Results - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025 21 Jan
Annual reports
Concalls
-
Jan 2026TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT
-
Jul 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Jul 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Apr 2024TranscriptAI SummaryPPT
-
Jan 2024Transcript PPT
-
Jan 2024TranscriptAI SummaryPPT
-
Oct 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Jan 2023TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
Busienss Overview:[1][2]
DBOL is an integrated sugarcane processing company with a growing presence in agri-business and bioenergy. It manufactures refined and raw sugar, bio-fuels, biomass-based renewable power, and other related products.